Literature DB >> 21087396

Reduced cardiac vagal activity in obese children and adolescents.

Frida Dangardt1, Reinhard Volkmann, Yun Chen, Walter Osika, Staffan Mårild, Peter Friberg.   

Abstract

OBJECTIVE: Obese children present with various cardiovascular risk factors affecting their future health. In adults, cardiac autonomic function is a major risk factor, predicting cardiovascular morbidity and mortality. We hypothesized that obese children and adolescents had a lower cardiac vagal activity than lean subjects. We measured cardiac spontaneous baroreflex sensitivity (BRS), reflecting the dynamic regulation of cardiac vagal function, in large groups of obese and lean young individuals. METHODS AND
RESULTS: Cardiac BRS, using the sequence approach, was assessed in 120 obese (59 girls), 43 overweight (23 girls) and 148 lean subjects (78 girls). Obese subjects showed a decreased BRS compared to both overweight and lean subjects [16±7 versus 21±9 (P<0·01) and 22±10 ms per mmHg (P<0·0001), respectively]. The differences remained after correcting for age, gender and pubertal status.
CONCLUSION: Children with obesity had low vagal activity at rest, and there was no gender difference.
© 2010 The Authors. Clinical Physiology and Functional Imaging © 2010 Scandinavian Society of Clinical Physiology and Nuclear Medicine.

Entities:  

Mesh:

Year:  2010        PMID: 21087396     DOI: 10.1111/j.1475-097X.2010.00985.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  12 in total

1.  Pentraxin 3: A Biomarker Link between Inflammation and Cardiovascular Risk among Obese Children.

Authors:  Yan-Ting Chen; Hui-Hsuan Wang; Ping-Yen Liu
Journal:  Acta Cardiol Sin       Date:  2021-03       Impact factor: 2.672

Review 2.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

3.  Childhood obesity and autonomic dysfunction: risk for cardiac morbidity and mortality.

Authors:  Duanping Liao; Sol M Rodríguez-Colón; Fan He; Edward O Bixler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

4.  Metabolic syndrome burden in apparently healthy adolescents is adversely associated with cardiac autonomic modulation--Penn State Children Cohort.

Authors:  Sol M Rodríguez-Colón; Fan He; Edward O Bixler; Julio Fernandez-Mendoza; Alexandros N Vgontzas; Susan Calhoun; Zhi-Jie Zheng; Duanping Liao
Journal:  Metabolism       Date:  2015-02-03       Impact factor: 8.694

5.  Pentraxin 3 as a Marker for Cardiovascular Disease Risk in Overweight and Obese Children.

Authors:  Pinar Dervisoglu; Bahri Elmas
Journal:  Acta Cardiol Sin       Date:  2021-03       Impact factor: 2.672

6.  Body mass index contributes to sympathovagal imbalance in prehypertensives.

Authors:  Gopal Krushna Pal; Adithan Chandrasekaran; Ananthanarayanan Palghat Hariharan; Tarun Kumar Dutta; Pravati Pal; Nivedita Nanda; Lalitha Venugopal
Journal:  BMC Cardiovasc Disord       Date:  2012-07-19       Impact factor: 2.298

7.  Sympathovagal Imbalance in Prehypertensive Offspring of Two Parents versus One Parent Hypertensive.

Authors:  G K Pal; Pravati Pal; Nivedita Nanda; V Lalitha; T K Dutta; C Adithan
Journal:  Int J Hypertens       Date:  2011-10-23       Impact factor: 2.420

8.  Association of sympathovagal imbalance with cardiovascular risks in overt hypothyroidism.

Authors:  Avupati Naga Syamsunder; Gopal Krushna Pal; Pravati Pal; Chandrakasan Sadishkumar Kamalanathan; Subhash Chandra Parija; Nivedita Nanda
Journal:  N Am J Med Sci       Date:  2013-09

9.  Growth hormone secretagogue receptor deficiency in mice protects against obesity-induced hypertension.

Authors:  Louise E Harris; David G Morgan; Nina Balthasar
Journal:  Physiol Rep       Date:  2014-03-20

10.  Effects of adiposity and Prader-Willi Syndrome on postexercise heart rate recovery.

Authors:  Diobel M Castner; Daniela A Rubin; Daniel A Judelson; Andrea M Haqq
Journal:  J Obes       Date:  2013-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.